$IBEX

Casteel Julie K sold $110K of IBEX

Casteel Julie K (Chief Sales/Marketing Officer) sold 3,600 shares of IBEX Ltd (IBEX) at $30.61 ($0.11M total) on 2026-06-11.

Original reporting
SEC EDGAR · Casteel Julie K
Published Jun 17, 2026, 12:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 17, 2026, 12:33 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$IBEX
Neutral
high confidence
Mentioned
$IBEX
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IBEXNeutralLow
01

Why it matters

This provides a fresh, verifiable datapoint on insider selling activity, but it does not include any new operational, financial, or regulatory catalyst for IBEX.

02

Market read

Traders may monitor for follow-on insider activity, but the disclosure alone is unlikely to drive a meaningful repricing.

03

What to watch

The article doesn’t state whether other insiders are selling/buying, nor does it provide total insider ownership changes beyond the post-transaction share count.

Relevance 4/10Novelty 6/10Timing: SEC Form 4 filed 2026-06-16 (covers sale dated 2026-06-11)

Background

The article is an SEC Form 4 insider transaction disclosure for IBEX Ltd, reporting an officer’s open-market sale.

Company-level read

Ticker impact

$IBEXNeutralHigh confidence
Context

IBEX insider Form 4 shows Casteel Julie K (Chief Sales/Marketing Officer) sold 3,600 shares at $30.6065 on 2026-06-11.

Expected impact

Low near-term impact; any reaction is likely muted unless part of a broader selling trend.

Evidence & confidence

The filing is a new SEC Form 4 disclosure, but it is an open-market sale with no 10b5-1 plan and no accompanying fundamental catalyst in the text.

Market effects

No sector-level implications; this is company-specific insider transaction data only.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs; without context, the signal may be overstated.

Key entities

  • IBEX Ltd

    Subject of the Form 4 insider transaction; officer sale disclosed.

  • Casteel Julie K

    Chief Sales/Marketing Officer who sold 3,600 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$IBEXHighAI 8/10

IBEX (IBEX) Turns The AI Threat Into Its Biggest Growth Engine

IBEX (IBEX) reported record full-year revenue of $644.1M, up 15.4%, and Q4 revenue of $164.3M, up 11.6%. Growth was driven by HealthTech, Technology, and Travel & Logistics. AI partnerships with Philippine Airlines and BJ's Wholesale showed strong results. Q4 net income fell to $8.7M, and EPS dropped to $0.59 due to training and operational costs.

$IBEXMedAI 8/10

IBEX (IBEX) Q4 2026 Earnings Call Transcript

IBEX (IBEX) reported fiscal year 2026 revenue of $644.1 million, up 15.4%, with Q4 revenue at $164.3 million, up 11.6%. Adjusted EBITDA reached $82.4 million, a 14.5% increase. HealthTech revenue grew 38.5% to $114 million. Guidance for 2027 projects revenue of $700M-$715M and adjusted EBITDA of $90M-$94M. The company highlighted growth in AI-powered services and strategic partnerships.

$IBEXHigh

IBEX Reports Record Fiscal Year 2026 Financial Results, Introduces Fiscal Year 2027 Guidance

IBEX Ltd (IBEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 IBEX Reports Record Fiscal Year 2026 Financial Results, Introduces Fiscal Year 2027 Guidance • Record fourth quarter revenue grew 12% versus prior year quarter, sixth consecutive quarter of double-digit growth • Nine new logo wins in the fourth quarter, including two